NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free PIII Stock Alerts $0.72 -0.03 (-3.50%) (As of 01:27 PM ET) Add Compare Share Share Today's Range$0.66▼$0.7950-Day Range$0.45▼$1.1652-Week Range$0.44▼$5.56Volume423,411 shsAverage Volume381,803 shsMarket Capitalization$227.45 millionP/E RatioN/ADividend YieldN/APrice Target$4.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get P3 Health Partners alerts: Email Address P3 Health Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside559.7% Upside$4.75 Price TargetShort InterestBearish4.57% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.14Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.56) to ($0.49) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.64 out of 5 starsMedical Sector653rd out of 915 stocksHealth Services Industry6th out of 10 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has only been the subject of 3 research reports in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.57% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in P3 Health Partners has recently increased by 5.61%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 2.9 News and Social Media Coverage News SentimentP3 Health Partners has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.36 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for P3 Health Partners this week, compared to 1 article on an average week.Search Interest7 people have searched for PIII on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.MarketBeat Follows3 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.56) to ($0.49) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. About P3 Health Partners Stock (NASDAQ:PIII)P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Read More PIII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesMay 8, 2024 | finance.yahoo.comP3 Health Partners Announces First Quarter 2024 ResultsMay 8, 2024 | finance.yahoo.comP3 Health Partners Names Dr. Aric Coffman as CEOMay 9, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.May 2, 2024 | businesswire.comP3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference CallApril 3, 2024 | businesswire.comP3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 28, 2024 | benzinga.comP3 Health Partners: Q4 Earnings InsightsMarch 28, 2024 | finance.yahoo.comP3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net LossMarch 28, 2024 | businesswire.comP3 Health Partners Announces Fourth Quarter and Full Year 2023 ResultsMay 9, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 17, 2024 | uk.investing.comP3 Health to report Q4 and full year 2023 earnings on March 28February 28, 2024 | businesswire.comP3 Health Partners to Participate in the Jefferies Value Based Healthcare SummitFebruary 19, 2024 | businesswire.comP3 Health Partners to Present at the TD Cowen 44th Annual Healthcare ConferenceJanuary 30, 2024 | finance.yahoo.comP3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 19, 2024 | finance.yahoo.comP3 Health Partners Inc.'s (NASDAQ:PIII) Path To ProfitabilityJanuary 10, 2024 | msn.comP3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimatesJanuary 10, 2024 | markets.businessinsider.comWhy Health Management Company P3 Health Partners Shares Are Up TodayJanuary 9, 2024 | markets.businessinsider.comP3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock UpJanuary 9, 2024 | finance.yahoo.comP3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024January 2, 2024 | finance.yahoo.comP3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2023 | morningstar.comP3 Health Partners Inc Class A PIIINovember 15, 2023 | markets.businessinsider.comPositive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health PartnersNovember 12, 2023 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | businesswire.com55,508November 8, 2023 | finance.yahoo.comP3 Health Partners Announces Third-Quarter and Year-to-Date 2023 ResultsNovember 3, 2023 | finance.yahoo.comP3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference CallOctober 29, 2023 | finance.yahoo.comSeveral Insiders Invested In P3 Health Partners Flagging Positive NewsOctober 20, 2023 | money.usnews.comP3 Health Partners Inc - Ordinary Shares - Class ASee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees400Year FoundedN/APrice Target and Rating Average Stock Price Target$4.75 High Stock Price Target$5.00 Low Stock Price Target$4.50 Potential Upside/Downside+536.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-57,770,000.00 Net Margins-4.56% Pretax Margin-14.51% Return on Equity-120.85% Return on Assets-6.54% Debt Debt-to-Equity Ratio0.76 Current Ratio0.55 Quick Ratio0.55 Sales & Book Value Annual Sales$1.27 billion Price / Sales0.19 Cash Flow$0.11 per share Price / Cash Flow6.79 Book Value$0.45 per share Price / Book1.66Miscellaneous Outstanding Shares315,903,000Free Float262,010,000Market Cap$235.70 million OptionableNot Optionable Beta1.26 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 63)FACP, M.D., Co-Founder, CEO & Director Comp: $7.1MDr. Amir Bacchus M.B.A. (Age 59)M.D., Co-Founder, Chief Medical Officer & Director Comp: $4.3MMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExecutive VP & COOMr. Devery GoodeySenior Vice President of TechnologyRoy YoungbloodDirector of ComplianceLeslie FisherSenior VP of Legal Affairs & General CounselMs. Kassi Belz APRExecutive Vice President of Communications, Culture & EngagementMr. Todd Lefkowitz MHAChief Managed Care OfficerMs. Sarah Bussmann B.S.N.CRNI, M.H.A., R.N., Chief of StaffMore ExecutivesKey CompetitorsGlobal Consumer AcquisitionNASDAQ:GACQSharecareNASDAQ:SHCROrion Biotech OpportunitiesNASDAQ:ORIAInternational Media AcquisitionNASDAQ:IMAQFrontier InvestmentNASDAQ:FICVView All CompetitorsInsiders & InstitutionsGSA Capital Partners LLPBought 296,936 shares on 5/3/2024Ownership: 0.179%Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/13/2023Total: $238,500.00 ($2.65/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/11/2023Total: $210,600.00 ($2.34/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/7/2023Total: $185,400.00 ($2.06/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/5/2023Total: $181,800.00 ($2.02/share)View All Insider TransactionsView All Institutional Transactions PIII Stock Analysis - Frequently Asked Questions Should I buy or sell P3 Health Partners stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PIII shares. View PIII analyst ratings or view top-rated stocks. What is P3 Health Partners' stock price target for 2024? 4 Wall Street research analysts have issued 1-year price targets for P3 Health Partners' stock. Their PIII share price targets range from $4.50 to $5.00. On average, they anticipate the company's stock price to reach $4.75 in the next year. This suggests a possible upside of 559.7% from the stock's current price. View analysts price targets for PIII or view top-rated stocks among Wall Street analysts. How have PIII shares performed in 2024? P3 Health Partners' stock was trading at $1.41 at the start of the year. Since then, PIII shares have decreased by 48.9% and is now trading at $0.72. View the best growth stocks for 2024 here. When is P3 Health Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024. View our PIII earnings forecast. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) announced its quarterly earnings results on Thursday, March, 28th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.03. The company had revenue of $346.86 million for the quarter, compared to the consensus estimate of $309.80 million. P3 Health Partners had a negative net margin of 4.56% and a negative trailing twelve-month return on equity of 120.85%. What guidance has P3 Health Partners issued on next quarter's earnings? P3 Health Partners updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.4 billion. Who are P3 Health Partners' major shareholders? P3 Health Partners' stock is owned by a number of institutional and retail investors. Top institutional investors include GSA Capital Partners LLP (0.18%). Insiders that own company stock include Atul Kavthekar, Michael Balkin, Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago and Sherif Abdou. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PIII) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
